Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (2), 241-245
- https://doi.org/10.1016/0959-8049(93)90183-g
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's SarcomaJNCI Journal of the National Cancer Institute, 1991
- Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.Journal of Clinical Oncology, 1991
- Extracranial primitive neuroectodermal tumors. The memorial sloan-kettering cancer center experienceCancer, 1991
- Intracellular dCTP/ARA-CTP Ratio and the Cytotoxic Effect of ARA-CCancer Investigation, 1991
- Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.JCI Insight, 1990
- Treatment of sarcomas of the chest wall using intensive combined modality therapyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Multidisciplinary treatment of primary Ewing's sarcoma of bone.A 6-year experience of a European cooperative trialCancer, 1988
- Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Indications for and benefits of intensive therapies in treatment of childhood cancersCancer, 1986
- The value of adjuvant chemotherapy in the management of sarcomas in childrenCancer, 1985